News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,833 Results
Type
Article (14323)
Company Profile (101)
Press Release (255409)
Section
Business (89375)
Career Advice (548)
Deals (15515)
Drug Delivery (66)
Drug Development (37711)
Employer Resources (51)
FDA (6368)
Job Trends (6316)
News (152651)
Policy (14211)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Pharm Country Standard (1)
Academia (551)
Adcomms (8)
Allergies (29)
Alliances (23504)
ALS (34)
Alzheimer's disease (785)
Antibody-drug conjugate (ADC) (33)
Approvals (6390)
Artificial intelligence (95)
Autoimmune disease (4)
Automation (3)
Bankruptcy (147)
Best Places to Work (4481)
BIOSECURE Act (9)
Biosimilars (49)
Biotechnology (42)
Bladder cancer (17)
Brain cancer (16)
Breast cancer (70)
Cancer (539)
Cardiovascular disease (55)
Career advice (477)
Career pathing (14)
CAR-T (17)
Cell therapy (77)
Cervical cancer (4)
Clinical research (31436)
Collaboration (297)
Compensation (122)
Complete response letters (16)
COVID-19 (781)
CRISPR (18)
C-suite (102)
Cystic fibrosis (35)
Data (562)
Denatured (15)
Depression (9)
Diabetes (73)
Diagnostics (1380)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (27)
Earnings (32311)
Editorial (11)
Employer branding (4)
Employer resources (48)
Events (38186)
Executive appointments (329)
FDA (6719)
Featured Employer (21)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (191)
Gene editing (34)
Generative AI (8)
Gene therapy (94)
GLP-1 (334)
Government (1323)
Grass and pollen (2)
Guidances (15)
Healthcare (3825)
Huntington's disease (6)
IgA nephropathy (8)
Immunology and inflammation (26)
Indications (10)
Infectious disease (811)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (35)
Interviews (74)
IPO (5953)
IRA (31)
Job creations (2068)
Job search strategy (428)
Kidney cancer (6)
Labor market (7)
Layoffs (180)
Leadership (7)
Legal (3469)
Liver cancer (18)
Lung cancer (75)
Lymphoma (46)
Machine learning (1)
Management (20)
Manufacturing (130)
MASH (28)
Medical device (1334)
Medtech (1336)
Mergers & acquisitions (9722)
Metabolic disorders (227)
Multiple sclerosis (16)
NASH (14)
Neurodegenerative disease (29)
Neuropsychiatric disorders (7)
Neuroscience (957)
NextGen: Class of 2025 (1673)
Non-profit (695)
Northern California (644)
Now hiring (7)
Obesity (128)
Opinion (124)
Ovarian cancer (18)
Pain (47)
Pancreatic cancer (15)
Parkinson's disease (47)
Partnered (5)
Patents (93)
Patient recruitment (29)
Peanut (9)
People (29330)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8218)
Phase II (13384)
Phase III (11870)
Pipeline (311)
Podcasts (44)
Policy (58)
Postmarket research (1408)
Preclinical (3303)
Press Release (25)
Prostate cancer (40)
Psychedelics (9)
Radiopharmaceuticals (122)
Rare diseases (151)
Real estate (2668)
Recruiting (18)
Regulatory (10146)
Reports (13)
Research institute (638)
Resumes & cover letters (72)
Rett syndrome (1)
RSV (6)
Schizophrenia (37)
Series A (34)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (638)
Special edition (6)
Sponsored (8)
Startups (1645)
State (2)
Stomach cancer (3)
Supply chain (29)
The Weekly (28)
United States (6508)
Vaccines (149)
Venture capitalists (13)
Webinars (10)
Weight loss (91)
Women's health (8)
Worklife (3)
Date
Today (44)
Last 7 days (248)
Last 30 days (1140)
Last 365 days (12741)
2025 (2277)
2024 (12929)
2023 (14649)
2022 (20024)
2021 (20598)
2020 (19494)
2019 (15391)
2018 (12049)
2017 (14152)
2016 (13385)
2015 (15759)
2014 (12697)
2013 (10804)
2012 (11595)
2011 (12109)
2010 (11010)
Location
Africa (330)
Alabama (13)
Alaska (1)
Arizona (48)
Arkansas (3)
Asia (20322)
Australia (2678)
California (1543)
Canada (823)
China (203)
Colorado (61)
Connecticut (63)
Delaware (49)
Europe (39825)
Florida (276)
Georgia (34)
Idaho (9)
Illinois (170)
India (11)
Indiana (122)
Iowa (1)
Japan (81)
Kansas (55)
Kentucky (12)
Maine (2)
Maryland (235)
Massachusetts (1333)
Michigan (27)
Minnesota (82)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (660)
New Mexico (8)
New York (495)
North Carolina (363)
North Dakota (2)
Northern California (644)
Ohio (44)
Oklahoma (4)
Oregon (16)
Pennsylvania (401)
Puerto Rico (5)
Rhode Island (6)
South America (519)
South Carolina (2)
Southern California (638)
Tennessee (32)
Texas (203)
Utah (32)
Virginia (66)
Washington D.C. (29)
Washington State (111)
Wisconsin (12)
269,833 Results for "sigma tau pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Press Releases
Alpha Tau to Participate in March Investor Conferences
February 27, 2025
·
1 min read
Drug Development
Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau
The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple approaches to slow cognitive decline.
September 9, 2024
·
6 min read
·
Gail Dutton
Press Releases
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
February 24, 2025
·
4 min read
Press Releases
Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer’s Tau Pathology in Blood
November 20, 2024
·
6 min read
Press Releases
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
January 27, 2025
·
14 min read
Alpha Tau to Present at the Jefferies Global Healthcare Conference
Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5 th , 2024.
May 21, 2024
·
1 min read
Press Releases
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease
March 4, 2025
·
8 min read
Press Releases
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
December 6, 2024
·
1 min read
Alpha Tau to Participate in May 2024 Investor Conferences
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.
May 1, 2024
·
1 min read
1 of 26,984
Next
